Pathogenesis of hepatitis C virus recurrence in the liver allograft

scientific article

Pathogenesis of hepatitis C virus recurrence in the liver allograft is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1053/JLTS.2002.35856
P698PubMed publication ID12362292
P5875ResearchGate publication ID11096171

P50authorAmany ZekryQ56968084
Geoffrey W McCaughanQ93355454
P2860cites workIntrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.Q43037625
A longitudinal analysis of hepatitis C virus replication following liver transplantationQ43047520
Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levelsQ43897811
Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantationQ44654522
Host genetic factors influence disease progression in chronic hepatitis C.Q45191664
Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.Q45765597
Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitisQ45853314
Insights into the Pathobiology of Hepatitis C Virus-Associated CirrhosisQ27478238
Analysis of successful immune responses in persons infected with hepatitis C virusQ27860698
Determinants of viral clearance and persistence during acute hepatitis C virus infectionQ28131757
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infectionQ29620141
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis CQ29620614
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis CQ29620791
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune responseQ29620891
Clinical and histologic patterns of early graft failure due to recurrnet hepatitis C in four patients after liver transplantationQ30468172
Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infectionQ34294938
Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infectionQ35358973
Reinfection of liver graft by hepatitis C virus after liver transplantationQ35601328
Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.Q38490006
Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virusQ38497824
Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokinesQ38506378
Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.Q38507365
Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent diseaseQ40819259
Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infectionQ40836214
The role of immune responses in the pathogenesis of hepatitis C virus infectionQ41681577
Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantationQ41704164
HCV-related fibrosis progression following liver transplantation: increase in recent yearsQ41732518
The association between hepatitis C infection and survival after orthotopic liver transplantationQ42672810
Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions.Q42980400
Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levelsQ42986489
Cholestatic hepatitis C in liver allograftsQ42988835
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.Q42997954
Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic studyQ42998125
Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gammaQ42999955
Involvement of the fas system in hepatitis C virus recurrence after liver transplantation.Q43000157
Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantationQ43000722
Influence of liver hepatitis C virus RNA and hepatitis C virus genotype on FAS-mediated apoptosis after liver transplantation for hepatitis C.Q43001097
High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcomeQ43029670
Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stagesQ43036009
Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liverQ43036220
Hepatitis C virus kinetics during and immediately after liver transplantation.Q43036834
P433issue10 Suppl 1
P407language of work or nameEnglishQ1860
P921main subjectHepatitis C virusQ708693
hepatitis CQ154869
P304page(s)S7-S13
P577publication date2002-10-01
P1433published inLiver TransplantationQ15730498
P1476titlePathogenesis of hepatitis C virus recurrence in the liver allograft
P478volume8

Reverse relations

cites work (P2860)
Q27011871Challenges of recurrent hepatitis C in the liver transplant patient
Q27485293Effect of Cell Polarization on Hepatitis C Virus Entry
Q38011694Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants
Q35621603Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation
Q43241172Hepatic lipid peroxidation and antioxidant micronutrients in hepatitis virus C liver recipients with and without disease recurrence.
Q37777154Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression.
Q44353697Hepatitis C virus-associated cholestatic hepatitis: we cannot seem to agree on diagnostic criteria
Q37654458Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review
Q35769705Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation.
Q26782017Impact of new treatment options for hepatitis C virus infection in liver transplantation
Q79117983Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors
Q42460742Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance
Q43040672Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation.
Q37352203Primary hepatocytes as targets for hepatitis C virus replication
Q35572080Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantation
Q35210857Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation
Q40458556Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation.
Q34280934Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis
Q45381807Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.
Q35835125Should patients with chronic hepatitis C infection be transplanted?
Q53096107Systematic investigation of elevated transaminases during the third posttransplant month.
Q53237682The dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients.

Search more.